Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Long-term Extension Study of Ligelizumab in Food Allergy

 		Food Allergy Phase3 United States
France
Spain
Germany
Italy
View All

CINC424A2X01B Rollover Protocol

 		Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia, Thalassemia Phase4 Japan
Italy
Korea, Republic of

Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials

 		Multiple Sclerosis Switzerland

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS

 		Multiple Sclerosis Phase3 France
Spain
Germany
Italy
View All

Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments

 		Advanced Solid Tumors Phase1 United States
Czechia
Hungary
China
Hong Kong
Spain
Italy
Switzerland
View All

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

 		Renal Angiomyolipoma Phase4 Taiwan

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

 		Age-Related Macular Degeneration Phase2 United States
United Kingdom
China

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

 		Multiple Sclerosis United States